Tech Center 1600 • Art Units: 1653
This examiner grants 12% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17429299 | MATERIALS AND METHODS FOR THE PREPARATION OF BACTERIAL CAPSULAR POLYSACCHARIDES | Final Rejection | The Regents of the University of California |
| 17995827 | METHOD OF PRODUCING POLYHYDROXYALKANOATE COPOLYMER MIXTURE AND TRANSFORMED MICROORGANISM | Non-Final OA | KANEKA CORPORATION |
| 18032456 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS | Non-Final OA | The Regents of the University of Michigan |
| 18042378 | Composition For Treating or Preventing Clostridium Difficile Infection | Non-Final OA | Seoul National University R&DB Foundation |
| 18329130 | METHODS FOR DETECTING ZEROVALENT NANOPARTICLE-MEDIATED OXIDATIVE STRESS IN CYANOBACTERIA | Non-Final OA | Morgan State University |
| 18025963 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | Non-Final OA | COLLAGEN MATRIX, INC. |
| 17613898 | GLUCONATE DEHYDRATASE ENZYMES AND RECOMBINANT CELLS | Non-Final OA | BP Corporation North America Inc. |
| 18006800 | IMPROVEMENTS TO WASH SOLUTIONS FOR ANION EXCHANGE CHROMATOGRAPHY IN A METHOD OF PURIFICATION OF RECOMBINANTLY-PRODUCED RSV PROTEINS | Non-Final OA | Pfizer Inc. |
| 17912114 | TREATMENT METHOD, PRODUCTION METHOD, AND HYDROXYAPATITE FILLER | Final Rejection | HOYA TECHNOSURGICAL CORPORATION |
| 18703591 | COMPOSITION FOR AMELIORATING HAIR LOSS COMPRISING BOTULINUM-DERIVED PEPTIDE | Non-Final OA | BPMED CO., LTD. |
| 18259613 | LOW LIPID CONTENT OAT PROTEIN COMPOSITION WITHOUT TRACES OF ORGANIC SOLVENT OR SURFACTANT | Non-Final OA | ROQUETTE FRERES |
| 17777939 | THERMOSTABLE PHYTASE VARIANTS | Non-Final OA | DUPONT NUTRITION BIOSCIENCES APS |
| 17904690 | METHODS FOR ENGINEERING AMINO ACID AMMONIA LYASE ENZYMES AND ENZYMES THEREBY OBTAINED | Non-Final OA | Trustees of Tufts College |
| 17906498 | PROTEIN CROSSLINKING METHOD | Final Rejection | Amano Enzyme Inc. |
| 18008820 | Engineered Bacterial Strain and Method of Use for One-Pot Vitamin C Synthesis | Non-Final OA | WiSys Technology Foundation, Inc. |
| 18559825 | IMPROVED METHODS AND CELLS FOR INCREASING ENZYME ACTIVITY AND PRODUCTION OF INSECT PHEROMONES | Non-Final OA | FMC AGRICUL TURAL SOLUTIONS A/S |
| 18482386 | METHOD AND COMPOSITION FOR THE TREATMENT OF CANCER | Non-Final OA | AntiCancer Inc. |
| 17633930 | COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS | Non-Final OA | Vedanta Biosciences, Inc. |
| 17795930 | COMPOSITION COMPRISING CARTILAGE INGREDIENT FOR REGENERATION OF CARTILAGE AND PREPARATION METHOD THEREFOR | Non-Final OA | L&C BIO Co., Ltd. |
| 18278937 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE | Non-Final OA | AEON Biopharma Sub, Inc. |
| 18083656 | METHODS AND KITS FOR ASSAYING A LARGE FLUID VOLUME USING FLOW CYTOMETRY | Final Rejection | HACH COMPANY |
| 18269869 | HEPATOCELLULAR CARCINOMA TREATMENTS, PROPHYLACTIC THERAPIES, AND COMPOSITIONS FOR USE THEREWITH | Non-Final OA | REPAIR BIOTECHNOLOGIES, INC. |
| 18035480 | COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER | Non-Final OA | EXOXEMIS, INC. |
| 18020048 | METHOD FOR PRODUCING PROTEIN COMPOSITIONS | Non-Final OA | HOFFMAN-LA ROCHE INC. |
| 18249097 | METHODS OF TREATING SKIN CANCERS | Non-Final OA | MEDIWOUND LTD. |
| 18030291 | LONG-ACTING DNASE | Final Rejection | Protalix Ltd. |
| 18190151 | AGAROSE-CELLULOSE NANOCOMPOSITE POROUS GEL MICROSPHERE, PREPARATION METHOD, AND APPLICATION | Non-Final OA | Hangzhou NeuroPeptide Biological Science and Technology Incorporation, Ltd. (NUPTEC) |
| 18007134 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS | Final Rejection | MUCPHARM PTY LTD |
| 18010511 | TRANSFORMANT OF GENUS HYDROGENOPHILUS BACTERIUM CAPABLE OF PRODUCING ASPARTIC ACID AND METHIONINE | Final Rejection | UTILIZATION OF CARBON DIOXIDE INSTITUTE CO., LTD. |
| 17797907 | MODIFIED MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF ECTOINE | Final Rejection | METABOLIC EXPLORER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy